These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25510810)
21. Cancer stem cells - A therapeutic target? Maitland NJ; Collins AT Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158 [TBL] [Abstract][Full Text] [Related]
22. Novel approaches to target cancer initiating cells-eliminating the root of the cancer. McCubrey JA; Abrams SL; Umezawa K; Cocco L; Martelli AM; Franklin RA; Chappell WH; Steelman LS Adv Biol Regul; 2012 Jan; 52(1):249-64. PubMed ID: 21930143 [No Abstract] [Full Text] [Related]
23. Cancer stem cells: an approach to identify newer therapeutic targets. Srivastava S; Krishna S J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597 [TBL] [Abstract][Full Text] [Related]
24. Cancer stem cells: biological functions and therapeutically targeting. Ciurea ME; Georgescu AM; Purcaru SO; Artene SA; Emami GH; Boldeanu MV; Tache DE; Dricu A Int J Mol Sci; 2014 May; 15(5):8169-85. PubMed ID: 24821540 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells. Oh J; Hlatky L; Jeong YS; Kim D Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325 [TBL] [Abstract][Full Text] [Related]
26. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy. Skipper HE; Simpson-Herren L Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935 [No Abstract] [Full Text] [Related]
27. Cancer stem cells and their potential implications for the treatment of solid tumors. Grotenhuis BA; Wijnhoven BP; van Lanschot JJ J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125 [TBL] [Abstract][Full Text] [Related]
28. Antibiotics for cancer therapy. Pestell RG; Rizvanov AA Oncotarget; 2015 Feb; 6(5):2587-8. PubMed ID: 25739117 [No Abstract] [Full Text] [Related]
29. Nanomaterials for targeted drug delivery to cancer stem cells. Orza A; Casciano D; Biris A Drug Metab Rev; 2014 May; 46(2):191-206. PubMed ID: 24697156 [TBL] [Abstract][Full Text] [Related]
30. Emerging approaches to target tumor metabolism. Ross SJ; Critchlow SE Curr Opin Pharmacol; 2014 Aug; 17():22-9. PubMed ID: 25048629 [TBL] [Abstract][Full Text] [Related]
31. Good cells gone bad: the cellular origins of cancer. Wang JC Trends Mol Med; 2010 Mar; 16(3):145-51. PubMed ID: 20149745 [TBL] [Abstract][Full Text] [Related]
34. Liver cancer stem cells: implications for a new therapeutic target. Lee TK; Castilho A; Ma S; Ng IO Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415 [TBL] [Abstract][Full Text] [Related]
35. Targeting a murky cancer reservoir: more researchers set their sights on cancer stem cells. Nelson B Cancer Cytopathol; 2013 Feb; 121(2):55-6. PubMed ID: 23408695 [No Abstract] [Full Text] [Related]
36. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
37. Lung cancer stem cells: tumor biology and clinical implications. Nurwidya F; Murakami A; Takahashi F; Takahashi K Asia Pac J Clin Oncol; 2012 Sep; 8(3):217-22. PubMed ID: 22897822 [TBL] [Abstract][Full Text] [Related]
38. Regulation of apoptosis pathways in cancer stem cells. Fulda S Cancer Lett; 2013 Sep; 338(1):168-73. PubMed ID: 22429999 [TBL] [Abstract][Full Text] [Related]
39. [Cancer stem cells and chemotherapy]. Gligorov J; Benderra MA; Zaoui M; Sabbah M; Larsen A Bull Cancer; 2017 Dec; 104(12):1085-1087. PubMed ID: 29162224 [No Abstract] [Full Text] [Related]